After COVID-19: Lung Cancer Screening and Treatment - Episode 5

Therapeutic Approaches in Small Cell Lung Cancer

Jacob Sands, MD, a physician at Dana-Farber Cancer Institute, as well as instructor of medicine at Harvard Medical School, provides a comprehensive review of the small cell lung cancer treatment paradigm, and how COVID-19 has limited treatment opportunities and continuation in patients.

EP. 1: Introducing the Post-Pandemic Change With Lung Cancer Screening
EP. 2: Opportunities and Challenges With Lung Cancer Screening Following COVID-19
EP. 3: How to Reduce Lung Cancer Screening Disparities After COVID-19
EP. 4: The Effects of COVID-19 and Vaccinations in Non–Small Cell Lung Cancer
Now Viewing
EP. 5: Therapeutic Approaches in Small Cell Lung Cancer
EP. 6: 2021 USPSTF Lung Cancer Screening Recommendations
EP. 7: Concluding Remarks in Lung Cancer Screening Following COVID-19

Jacob Sands, MD, a physician at Dana-Farber Cancer Institute, as well as instructor of medicine at Harvard Medical School, provides a comprehensive review of the small cell lung cancer treatment paradigm, and how COVID-19 has limited treatment opportunities and continuation in patients.